Resverlogix Corp. (RVXCF)

[noretreat]

Excerpt from an unpaid analysis: "We believe that Resverlogix is one of the most undervalued and most impressive biotechnology companies listed on the TSX. From its gamechanging medical technology platform and drug development platform, to its present stage of development and deeply talented senior management team, this company has flown under the radar of “healthcare and biotechnology-focused” investment banks, which is unfortunate (or fortunate for future investors), given the company’s blockbuster market potential. Epigenetics and BET inhibition are among the hottest and most novel biological processes presently being investigated and invested in by “big pharma” companies"